2006 | Foundation and Early Stage

UTop Pharma was founded in China, focusing on the research and production of Active Pharmaceutical Ingredients (APIs). From the beginning, the company has adhered to the philosophy of “Science-driven, Quality-oriented,” providing high-standard raw materials for global pharmaceutical partners.

2009 | GMP Certification and International Expansion

UTop Pharma obtained national GMP certification and began exporting products to Southeast Asia and South America, marking the company’s first step toward internationalization.

2013 | Establishment of R&D Center and Entry into Peptide Sector

UTop Pharma established an independent R&D center dedicated to peptide-based APIs and advanced synthesis technologies, reinforcing its position as a high-value ingredient innovator.

2016 | New Manufacturing Base and Entry into the European Market

A new production facility meeting EU GMP standards was launched, enabling UTop Pharma’s products to enter the European market and elevating the company to a global pharmaceutical supplier.

2018 | ISO 9001 Certification and Global Partnerships

UTop Pharma achieved ISO 9001 certification and established strategic collaborations with several international pharmaceutical companies, strengthening its global distribution network.

2020 | Launch of UTop Peptide Platform

UTop Pharma launched the “UTop Peptide Platform,” offering comprehensive peptide synthesis, purification, and analytical services for research, nutraceutical, and pharmaceutical applications.

2024 | Brand Upgrade and Future Strategy

UTop Pharma rebranded as UTop Pharma Co., Ltd., strengthening its focus on three strategic areas — peptide therapeutics, innovative APIs, and nutraceutical peptides — with the vision of becoming a global life science solution provider.